Home · Learn · DSCSA Serialization: 2026 Requirements, Deadlines, and Implementation
DSCSA Serialization: 2026 Requirements, Deadlines, and Implementation
The Drug Supply Chain Security Act mandates serialized pharmaceuticals across the US. Here is the 2026 compliance picture — what's enforced, what's coming, and how to implement.
DSCSA (Drug Supply Chain Security Act) is the US federal law requiring unit-level serialization of prescription drugs. Every saleable unit must carry a 2D GS1 DataMatrix barcode encoding the GTIN, lot number, expiration date, and a unique serial number. Wholesalers and dispensers must verify serial numbers against authorized trading partner systems before accepting or shipping inventory.
Through May 27, 2026, FDA is in the DSCSA Stabilization Period — enforcing unit-level serialization but NOT full aggregation and EPCIS data exchange. Starting May 28, 2026, full enforcement begins: aggregation between unit, case, and pallet levels is mandatory, and EPCIS data must flow between manufacturers, wholesalers, and pharmacies in near-real-time.
The GS1 DataMatrix format DSCSA requires
Every saleable unit barcode encodes four GS1 Application Identifiers: (01) the 14-digit GTIN, (17) YYMMDD expiry date, (10) lot number, (21) unique serial number. Example payload: (01)00614141999996(17)281231(10)LOT123(21)SN9876543210. Rendered as a 2D Data Matrix at minimum 5×5mm. Print quality grade B (ISO 15415) or higher — bad print = rejected case at wholesaler receiving.
DSCSA Stabilization Period (through May 27, 2026)
FDA's Stabilization Period extension lets the industry phase in compliance. Required NOW: unit-level serialization on every Rx package, GS1 DataMatrix with the four AIs, registration in the FDA's GUDID-equivalent system for trading partners. NOT enforced yet: full aggregation (parent-child relationships between unit/case/pallet), EPCIS event data exchange, T1/T2/T3 commissioning/packing/shipping events. Most manufacturers ARE implementing aggregation now to avoid a May 2026 scramble.
What changes May 28, 2026
Three big shifts: (1) Aggregation becomes mandatory — every case must report which unit serials it contains; every pallet must report which case serials it contains. (2) EPCIS 1.2+ data exchange between authorized trading partners (manufacturers → wholesalers → pharmacies). (3) Wholesalers and pharmacies will REJECT non-aggregated or non-EPCIS-compliant product. Manufacturers who haven't implemented by May 2026 will have product stuck at the wholesaler dock.
How to implement DSCSA serialization
Most pharma manufacturers use a serialization platform: Tracelink, SAP ATTP, Adents, Antares Vision, RFXcel. These vendors allocate unique serial numbers within your GTIN namespace, print the GS1 DataMatrix on packaging, aggregate units into cases and pallets, and exchange EPCIS data with trading partners. Cost: $200k-$2M+ to implement depending on volume. DIY EPCIS is technically possible but every plant I've seen uses one of the major platforms — the integration complexity is too high for in-house teams.
International parallels: EU FMD, Brazil ANVISA, Saudi SFDA
DSCSA is one of several global serialization regimes. EU FMD (Falsified Medicines Directive) has required serialization since February 2019 — uses the same GS1 DataMatrix format, exchanged through EU Hub + national NMVOs. Brazil ANVISA SNCM requires serialization on all Rx since 2022. Saudi Arabia SFDA Rasd requires serial reporting BEFORE shipment into the country. Global manufacturers maintain multiple parallel serialization systems for each market.
FAQ
What is DSCSA?
DSCSA is the Drug Supply Chain Security Act, the US federal law requiring unit-level serialization of prescription drugs. Every saleable Rx unit must carry a 2D GS1 DataMatrix with GTIN, lot, expiration, and unique serial number. Manufacturers, wholesalers, and pharmacies are all part of the compliance chain.
What is the DSCSA deadline?
Two phases. Through May 27, 2026: Stabilization Period — unit-level serialization required, but full aggregation and EPCIS exchange not enforced. From May 28, 2026: full enforcement — aggregation and EPCIS mandatory. Manufacturers who haven't implemented by then will have product rejected at wholesaler receiving.
What is DSCSA serialization?
Adding a unique serial number to every individual saleable unit of prescription drug, encoded in a 2D GS1 DataMatrix alongside GTIN, lot, and expiration. The serial number lets wholesalers and pharmacies verify each unit against the manufacturer's authorized records — preventing counterfeit drugs from entering the legitimate supply chain.
What is the DSCSA Stabilization Period?
FDA's extended phase-in window. Active through May 27, 2026. During this period, FDA enforces unit-level serialization (every package has a GS1 DataMatrix with the four AIs) but NOT full aggregation or EPCIS data exchange. From May 28, 2026, the full DSCSA rules become enforceable.
What barcode format does DSCSA require?
GS1 DataMatrix (2D matrix barcode) encoding four Application Identifiers: (01) GTIN, (17) expiry date, (10) lot number, (21) unique serial number. Minimum print size 5×5mm. Print quality grade B (ISO 15415) or higher required for wholesaler acceptance.
Do I need a serialization platform for DSCSA?
Almost certainly yes. Tracelink, SAP ATTP, Adents, Antares Vision, and RFXcel are the major DSCSA serialization platforms. Implementation costs $200k-$2M+ depending on plant volume. DIY EPCIS is technically possible but every pharma manufacturer in production uses one of these vendors — the trading-partner integration complexity is too high for in-house IT teams.
Related generators
Need a real barcode now?
Generate a valid Data Matrix barcode in seconds — no signup, no watermark. Free for casual use; paid plans from $9/mo for higher volume.